Chemotherapy and Radiotherapy for Locally Advanced Breast Cancer
Author Information
Author(s): A. Rodger, W.J.L. Jack, P.D.J. Hardman, G.R. Kerr, U. Chetty, R.C.F. Leonard
Primary Institution: Western General Hospital, Edinburgh; University Department of Surgery, Royal Infirmary, Edinburgh
Hypothesis
Does the combination of chemotherapy and radiotherapy improve outcomes in patients with locally advanced breast cancer compared to radiotherapy alone?
Conclusion
The study suggests that combining chemotherapy with radiotherapy has only marginal value in improving prognosis for locally advanced breast cancer.
Supporting Evidence
- Twenty-four patients were treated in a phase II study with chemotherapy before radiotherapy.
- Fifty-two patients were randomized in a phase III trial comparing two treatment approaches.
- The complete response rate was significantly higher in the chemotherapy plus radiotherapy group.
Takeaway
Doctors tested a new treatment for breast cancer that combines medicine and radiation. They found that while it helped some people, it didn't make a big difference in how long they lived.
Methodology
The study involved a phase II trial with 24 patients followed by a phase III trial with 52 patients, comparing chemotherapy plus radiotherapy to radiotherapy alone.
Potential Biases
Potential bias due to the exclusion of patients with certain conditions and the randomization process.
Limitations
The study had a small sample size and the follow-up period varied among patients.
Participant Demographics
Patients were primarily women with stage T4 breast cancer, aged 34 to 69 years.
Statistical Information
P-Value
0.03
Statistical Significance
p = 0.03
Want to read the original?
Access the complete publication on the publisher's website